Kansallinen Varautumissuunnitelma Influenssapandemiaa Varten

Objectives

Finland’s national influenza pandemic preparedness plan aims to limit harm to population health and safeguard the continuity of essential societal functions. It provides a common national framework for pandemic development and impacts, surveillance, leadership and powers, healthcare policies, ethical issues, material preparedness, communications, legislation and cross-sector cooperation.[1]The plan is designed for flexible application according to the assessed severity of an emerging pandemic threat or pandemic.[2]

• Guide preparedness across national, regional and local health and social care administration, while supporting preparedness in all other administrative sectors.[3]
• Detect new influenza variants, unusual human and animal infections, and emerging transmission chains early enough to prevent or delay a pandemic where possible.[4][5]
• Reduce transmission and the peak burden on health services through hygiene, respiratory etiquette, isolation, early care-seeking, social-distancing measures, vaccination, antiviral treatment and other proportionate non-pharmaceutical measures.[6][7][8]
• Protect healthcare workers and maintain service capacity, recognising that staff protection, safe patient pathways, adequate supplies and continuity arrangements are essential to treating patients and preserving wider societal functions.[9][10]
• Secure pandemic vaccines for the whole population through advance purchase-reservation arrangements, while prioritising vaccines and antivirals ethically when supplies are initially constrained.[11][12][13]
• Maintain preparedness for other serious global epidemics and strengthen routine communicable-disease control structures that protect population health.[14]
• Prepare against a severe planning scenario in which 35% of Finland’s population could become infected during an approximately eight-week first wave, potentially causing 11,000 to 36,000 hospitalisations and 3,500 to 9,000 deaths.[15]
• Apply World Health Organization pandemic phases to structure preparedness, from routine inter-pandemic surveillance through intensified alert-phase containment, pandemic mitigation and post-pandemic evaluation.[16][17]

Implementation

The plan uses an integrated, all-government delivery model led nationally by the Government and the Ministry of Social Affairs and Health, with implementation through regional authorities, hospital districts, municipalities and joint municipal authorities.[18][19]Detailed sectoral plans must be aligned with the national plan, regularly updated, exercised and adapted as information about the virus, severity, transmission and service pressures becomes available.[20][21][22]

• Coordinate national policy through the Ministry of Social Affairs and Health, supported by the Finnish Institute for Health and Welfare, the Advisory Board on Communicable Diseases, its pandemic division and, where necessary, a Pandemic Coordination Group or national command centre.[23][24]
• Assign ministries responsibility for preparedness in their own sectors, require annual review of sectoral plans, and use preparedness directors and permanent secretaries to coordinate cross-government action.[20][21]
• Lead regional preparedness through Regional State Administrative Agencies, which supervise, coordinate and exercise plans with hospital districts, municipalities, social services, private providers and occupational health services.[25][26]
• Place municipal communicable-disease authorities at the centre of local response, with hospital-district infectious-disease physicians providing regional and local expert support for planning, diagnosis, outbreak investigation and control.[14][27]
• Maintain national and international surveillance through laboratory reporting, the national communicable disease register, sentinel clinical surveillance, hospital and intensive-care reporting, mortality monitoring, animal surveillance and information exchange with the World Health Organization, the European Centre for Disease Prevention and Control and European Union systems.[4][28][29]
• Adapt reporting as case numbers rise, moving from detailed reporting of tested cases towards surveillance of confirmed cases, hospitalisations and deaths, while making relevant information available promptly to response actors.[30]
• Implement phase-specific containment through case definitions, laboratory confirmation, contact tracing, voluntary home quarantine, isolation, social support and targeted antiviral prophylaxis during alert phases; discontinue extensive tracing when widespread transmission makes it ineffective.[31][32][33]
• Organise healthcare delivery through separate telephone advice, influenza reception areas, remote triage, designated patient pathways, cohorting, isolation, home care, reserve facilities, staff redeployment and restriction of non-urgent activity when service pressure requires it.[34][35][36]
• Maintain medicine, vaccine and supply security through state emergency stocks, statutory stockholding, cold-chain vaccine logistics, rapid distribution channels, protective-equipment reserves and local assessments of medicines, intensive-care capacity and clinical consumables.[37][38][39][40]
• Deliver mass vaccination through health centres, hospitals, occupational health services, social care, education settings and contracted private providers, supported by advance planning for staffing, premises, equipment, registration, traceability and adverse-event monitoring.[41][42][43]
• Apply legal powers under communicable-disease and emergency legislation for notification, isolation, quarantine, closure of institutions, restrictions on gatherings, compulsory healthcare work and temporary service reorganisation when voluntary or routine measures are insufficient.[44][45][46]
• Coordinate communication through the Ministry of Social Affairs and Health and the Finnish Institute for Health and Welfare, with ministries, regional authorities and local services responsible for their operational areas; use multilingual, accessible and multi-channel public and professional communication, while monitoring misinformation and public concerns.[47][48][49]
• Review performance after a pandemic, assess further-wave risks and resource needs, use antibody studies and epidemiological evidence, and incorporate lessons into updated national, regional and municipal plans.[17]

Monitoring & Evaluation

The plan establishes a multi-level monitoring, surveillance and review system to detect pandemic threats early, assess severity and spread, guide phase-specific action, monitor health-service pressure and vaccine or medicine safety, and update preparedness arrangements as evidence changes.[4][50][17]

• Maintain national influenza surveillance through laboratory notifications to the communicable diseases register, sentinel sampling, virus typing and subtyping, antigenic and genetic analysis, and clinical surveillance of influenza-like illness.[51][4][28]
• Exchange findings through World Health Organization FluNet, the European Influenza Surveillance Network, the European Centre for Disease Prevention and Control TESSy system, and international early-warning arrangements.[4][52][53]
• Monitor animal influenza in poultry, wild birds, pigs and horses through the Finnish Food Safety Authority, with notification and outbreak-control measures for specified findings.[54]
• Use phase-specific surveillance to intensify case detection and laboratory confirmation during World Health Organization phases 3 to 5, then track regional epidemic onset, progression and conclusion during phase 6.[55][31]
• Collect case-level information on exposure, symptoms, treatment, vaccination history, severity, intensive care, ventilation and death through hospital districts, electronic forms and web-based reporting systems.[28][30]
• Track healthcare burden through influenza-like illness consultations, emergency visits, hospital admissions, inpatient episodes, intensive-care occupancy, mechanical ventilation, institutional absences and antiviral consumption.[29][56]
• Monitor vaccination coverage, vaccine traceability and adverse effects through vaccination records, the adverse-effect register and enhanced safety surveillance.[43][57][58]
• Monitor medicine reserves through annual notifications to the Finnish Medicines Agency, known as Fimea, and assess vaccine cold-chain performance through continuous temperature surveillance.[37][59]
• Require the Ministry of Social Affairs and Health, known as STM, and ministries to review preparedness, with each ministry reviewing its sectoral plan at least annually; use preparedness exercises to test functionality and revise plans where necessary.[20][21]
• Require notification to the World Health Organization within 24 hours of events that may constitute an international public-health emergency under the International Health Regulations.[60][61]

Accountability is primarily embedded in statutory reporting, supervisory functions and defined leadership responsibilities. Regional State Administrative Agencies supervise and coordinate regional planning and implementation, municipalities report situation information according to regional instructions, and national command arrangements use regional reports and surveillance data to maintain a real-time situation picture.[14][62][63]Formal performance indicators, common evaluation methodologies, public accountability processes and routine reporting timetables are generally not specified beyond the named surveillance, plan-review and exercise requirements.[3][20][17]

Costing & Financing

The plan identifies substantial resource needs for preparedness and response, but provides few quantified budgets or unit costs. Financing responsibilities span central government, municipalities or joint municipal authorities, employers, sickness insurance, statutory stockholders and healthcare organisations.[64][65][66]

• Provide central-government financing for pandemic vaccines procured centrally, while sharing other pandemic-related additional costs between the state and municipalities or joint municipal authorities.[64]
• Include the annual fee for a pandemic-vaccine delivery reservation agreement in STM revenue and expenditure estimates and central-government expenditure frameworks; no fee amount is specified.[67][58]
• Maintain state-owned emergency reserves of antivirals, medicines, medical materials and protective equipment through the National Emergency Supply Agency, while requiring statutory stockholding by manufacturers, importers and healthcare units.[38][59][68]
• Require hospital districts and health centres to finance medicines, supplies and protective equipment not held in the national emergency reserve, while state appropriations may support regional preparedness expertise.[65][40]
• Fund occupational health services through employers, with compensation available through employment income insurance up to an unspecified upper limit.[69]
• Finance outpatient medicine reimbursement equally through insured persons’ sickness-insurance medical-care contributions and the state funding share.[70]
• Provide free investigation, treatment, prescribed medicines and institutional isolation for generally hazardous communicable diseases, and provide vaccines free to municipalities and joint municipal authorities.[45]
• Provide sickness allowance and compensation for lost earnings to people prevented from working by isolation, quarantine or related disease-control measures.[45]
• Specify in private-service procurement contracts which party bears exceptional pandemic-related costs.[13]

Resource pressures include protective equipment, cold storage, vaccination equipment, trained staff, antiviral distribution, intensive-care capacity, patient transport, communications, social support and continuity of essential services.[39][71][65]The plan also identifies quarantine-related expenditure risks, including income losses, care charges, staffing, medicines, vaccines, equipment, premises, training and social-security demand.[64]

The only recurring quantified national appropriation identified is 5 million euros in the 2012 Ministry of Finance main budget for unavoidable and unforeseeable expenditure lacking a separate appropriation.[72]Economic evidence cited includes estimated losses from the 2003 Severe Acute Respiratory Syndrome epidemic of 60 billion US dollars across South-East Asia and 2 billion Canadian dollars in Toronto.[73]The source does not provide a total pandemic budget, comprehensive costing, quantified funding gap, cost-effectiveness analysis or wider economic assumptions for implementing the plan.[64][65]